Cargando…
SARS-CoV-2 and myocardial injury: a role for Nox2?
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be complicated by myocardial injury but at-risk patients as well as mechanism of disease are unclear. We gathered data regarding troponin levels in the so far reported SARS-CoV-2 patients and found a large variability in terms of tropo...
Autores principales: | Violi, Francesco, Pastori, Daniele, Pignatelli, Pasquale, Cangemi, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214847/ https://www.ncbi.nlm.nih.gov/pubmed/32399954 http://dx.doi.org/10.1007/s11739-020-02348-6 |
Ejemplares similares
-
Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients
por: Testa, Sophie, et al.
Publicado: (2020) -
Aerosol delivery systems for treating obstructive airway diseases during the SARS-CoV-2 pandemic
por: Lavorini, Federico, et al.
Publicado: (2021) -
Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines
por: Marcucci, Rossella, et al.
Publicado: (2021) -
The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies
por: Albini, Adriana, et al.
Publicado: (2020) -
Effect of corticosteroids on myocardial injury among patients hospitalized for community-acquired pneumonia: rationale and study design. The colosseum trial
por: Violi, Francesco, et al.
Publicado: (2019)